, /PRNewswire/ — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, included DeepIntent’s HealthFirst Vaccine Audiences in its annual Innovations Issue, which highlights the most interesting advancements in the life sciences, healthcare, and marketing in 16 categories. HealthFirst Vaccines Audiences was included within the Marketing Technology/Services category.
Launched in July 2024, HealthFirst Vaccine Audiences is a groundbreaking solution that combines advanced audience modeling with real-world health data to deliver more effective vaccine advertising campaigns.
Unique in its ability to integrate real-world vaccine data from trusted sources such as government agencies and retail pharmacies, HealthFirst Vaccine Audiences also includes a custom “propensity score” to ensure ads reach audiences that are most receptive to vaccination.
By incorporating clinical insights, demographic data, and local vaccine incidence rates, marketers can significantly reduce media waste and drive measurable vaccination lift. Additionally, marketers can activate more impactful vaccine campaigns across …